Venus Medtech (Hangzhou) Inc. (HKG:2500)
1.920
+0.060 (3.23%)
At close: Mar 27, 2026
Venus Medtech (Hangzhou) Revenue
Venus Medtech (Hangzhou) had revenue of 187.14M CNY in the half year ending June 30, 2025, a decrease of -26.79%. This brings the company's revenue in the last twelve months to 427.25M, down -8.41% year-over-year. In the year 2024, Venus Medtech (Hangzhou) had annual revenue of 470.83M, down -4.18%.
Revenue (ttm)
427.25M CNY
Revenue Growth
-8.41%
P/S Ratio
1.80
Revenue / Employee
706.20K CNY
Employees
605
Market Cap
840.76M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 470.83M | -20.54M | -4.18% |
| Dec 31, 2023 | 491.37M | 84.91M | 20.89% |
| Dec 31, 2022 | 406.46M | -9.40M | -2.26% |
| Dec 31, 2021 | 415.86M | 139.82M | 50.65% |
| Dec 31, 2020 | 276.05M | 42.78M | 18.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.84B |
| Yestar Healthcare Holdings Company | 2.12B |
| Austar Lifesciences | 1.60B |
| Gaush Meditech | 1.58B |
| Vincent Medical Holdings | 932.78M |
| MicroTech Medical (Hangzhou) | 482.95M |
| Shanghai HeartCare Medical Technology Corporation | 367.02M |
| Suzhou Basecare Medical Corporation | 302.12M |
Venus Medtech (Hangzhou) News
- 1 year ago - Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations - PRNewsWire
- 1 year ago - Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study - PRNewsWire
- 1 year ago - Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. - PRNewsWire
- 2 years ago - Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval - PRNewsWire
- 2 years ago - Venus Medtech's Exciting Innovations for Structural Heart to Be Showcased at London Valves 2023 - PRNewsWire